Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Development of a provincial inpatient diabetes database to study and improve quality of care for patients with diabetes using pharmacoepidemiologic and machine learning methods

FY 2020-21

Summary
Diabetes is among the most prevalent chronic medical conditions, affecting roughly 30% of adults by age 65. Patients with diabetes are frequently hospitalized, both for complications directly related to their diabetes control, and secondary problems associated with diabetes such as heart attack and stroke. There is currently an absence of data on patients with diabetes while they are hospitalized. This presents a barrier to completing high quality studies of inpatient diabetes care and presents an opportunity to improve the inpatient management of adults with diabetes. Our study involves three components: 1. First, we will create a database of adults hospitalized with diabetes across the 30 hospitals in Ontario using the GEMINI (GEneral Medicine INpatient Initiative) database. Preliminary analyses have shown that this cohort will consist of rougly 200,000 patients with diabetes. 2. Second, we will conduct a pharmacoepidemiologic study to assess the use SGLT2 inhibitors and GLP1 agonists among patients who are eligible for these medications and risk of cardiovascular outcomes and mortality in the year after hospitalization. These agents have been shown to reduce the risk of heart attack, stroke, and death, and the identification of barriers to their use is essential for improving care for patients with diabetes. Studies in the United States have suggested that less than 5% of eligible patients receive these medications. 3. Third, we will develop a machine learning tool to predict and prevent inpatient hypoglycemia. This is among the most serious adverse events occurring in patients with diabetes and can result in seizure, coma and death.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
449715
Name
Colacci Michael
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Development of a provincial inpatient diabetes database to study and improve quality of care for patients with diabetes using pharmacoepidemiologic and machine learning methods
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adverse Event Prevention; Cardiovascular Risk Reduction; Diabetes; Healthcare Dabatase; Inpatient Care; Machine Learning; Pharmacoepidemiology; Population Health
Abstract
Diabetes is among the most prevalent chronic medical conditions, affecting roughly 30% of adults by age 65. Patients with diabetes are frequently hospitalized, both for complications directly related to their diabetes control, and secondary problems associated with diabetes such as heart attack and stroke. There is currently an absence of data on patients with diabetes while they are hospitalized. This presents a barrier to completing high quality studies of inpatient diabetes care and presents an opportunity to improve the inpatient management of adults with diabetes. Our study involves three components: 1. First, we will create a database of adults hospitalized with diabetes across the 30 hospitals in Ontario using the GEMINI (GEneral Medicine INpatient Initiative) database. Preliminary analyses have shown that this cohort will consist of rougly 200,000 patients with diabetes. 2. Second, we will conduct a pharmacoepidemiologic study to assess the use SGLT2 inhibitors and GLP1 agonists among patients who are eligible for these medications and risk of cardiovascular outcomes and mortality in the year after hospitalization. These agents have been shown to reduce the risk of heart attack, stroke, and death, and the identification of barriers to their use is essential for improving care for patients with diabetes. Studies in the United States have suggested that less than 5% of eligible patients receive these medications. 3. Third, we will develop a machine learning tool to predict and prevent inpatient hypoglycemia. This is among the most serious adverse events occurring in patients with diabetes and can result in seizure, coma and death.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Colacci, Michael
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~